quinuclidines has been researched along with Depression in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, W; Sun, C; Sun, X; Zhai, L | 1 |
LEVIT, VG; SMULEVICH, AB | 1 |
Balashova, LN; Gromova, VV | 1 |
3 other study(ies) available for quinuclidines and Depression
Article | Year |
---|---|
A Selective M
Topics: Animals; Antidepressive Agents; Astrocytes; Brain-Derived Neurotrophic Factor; Depression; Hindlimb Suspension; Hippocampus; Male; Mice, Inbred ICR; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neuroglia; Quinuclidines; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Stress, Psychological; Swimming | 2019 |
[USE OF OXYLIDINE IN THE AMBULATORY TREATMENT OF MENTAL PATIENTS].
Topics: Anxiety; Anxiety Disorders; Cardiovascular Diseases; Delusions; Depression; Guilt; Humans; Hypnotics and Sedatives; Hypochondriasis; Mentally Ill Persons; Meprobamate; Neurotic Disorders; Obsessive-Compulsive Disorder; Paranoid Disorders; Phobic Disorders; Quinuclidines; Schizophrenia; Tranquilizing Agents | 1963 |
[The use of oxylidin in psychiatric practice].
Topics: Adult; Aged; Depression; Female; Ganglionic Blockers; Hallucinations; Humans; Hypochondriasis; Hypotension; Male; Mental Disorders; Middle Aged; Paranoid Disorders; Quinuclidines; Schizophrenia | 1968 |